Funding for this research was provided by:
National Health and Medical Research Council (APP1122332)
Received: 23 October 2020
Accepted: 5 May 2021
First Online: 26 May 2021
: In 2020, Barbara Mintzes acted as an expert witness for Health Canada on a legal case concerning marketing of an unapproved product. She is also a member of Health Action International (HAI-Europe), a non-profit organisation that supports access to essential medicines and public interests in pharmaceutical policy. Adam Dunn reports grants from National Health and Medical Research Council (Australia) and National Library of Medicine (US), during the conduct of the study. The remaining authors declare no other relationships or activities that could appear to have influenced the submitted work.
: The funding source had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.